A Kuroiwa < A Kurtaran < A Kushelevsky

Facettes :

List of bibliographic references indexed by A Kurtaran

Number of relevant bibliographic references: 19.

Ident.	Authors (with country if any)	Title
003556 (2002)		Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
003610 (2002)		Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression.
003734 (2001)		New trends in peptide receptor radioligands.
003826 (2001)		Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
003865 (2001)		111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung.
003879 (2000)		Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998.
003959 (2000)		New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.
003A69 (2000)		An unusual visualization of the gallbladder by somatostatin receptor (SSTR) scintigraphy: usefulness of hepatobiliary imaging for differential diagnosis.
003D30 (1999)		"MAURITIUS": tumour dose in patients with advanced carcinoma.
003D48 (1998)		Visualization of intestinal splenosis by somatostatin receptor scintigraphy.
003D90 (1998)		Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma.
003E41 (1998)		Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy.
003E63 (1998)		Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
003E64 (1998)		Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
003F84 (1997)		Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
004055 (1997)		Radiation doses deriving from patients undergoing 111In-DTPA-D-phe-1-octreotide scintigraphy.
004414 (1996)		In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.
004480 (1996)		Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.
004486 (1996)		Combined use of 111In-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC).

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "A Kurtaran" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "A Kurtaran" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    A Kurtaran
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024